drugset / Trial / NCT02377999

Safety and Efficacy of Repeat Use of Picato® 0.05% in the Treatment of Anogenital Warts

NCT02377999

Phase 2 Completed 40 enrolled LEO Pharma
NaSingle-groupOpen-labelTreatment

Summary

An exploratory open label, single treatment trial of anogenital warts with Picato® repeated up to 2 times with two weeks intervals.

Timeline

Start
2015-02
Primary completion
2015-11
Completion
2015-11

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule 0.05 %